BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR GG CENTRE COMORB GRADE HISTO AGE HIST SIZE MM MENOP HER2 NODES GGI ER
GSM1061142 1 equivocal 1 average for age 2 80 lobular 15 postmenopausal 0 0 -0.3 1
GSM106114 1 equivocal 1 minor 1 75 ductal 10 postmenopausal 0 0 0.2 1
GSM1061140 0 3 1 minor 3 42 ductal 17 premenopausal 0 0 2 1
GSM1061139 1 1 1 minor 1 51 ductal 11 postmenopausal 0 0 -1.5 1
GSM1061138 1 3 1 minor 3 41 ductal 16 NA 1 0 0.6 1
GSM1061137 0 3 6 perfect health 3 48 ductal 28 premenopausal 0 0 3.1 1
GSM1061136 1 3 6 perfect health 3 60 ductal 8 postmenopausal 1 0 0.5 1
GSM1061135 0 1 6 perfect health 1 56 ductal 12 NA 0 0 -0.6 1
GSM1061134 0 3 6 major problems 2 78 ductal 45 postmenopausal 0 1 0.4 1
GSM1061133 1 1 6 perfect health 2 43 ductal 12 premenopausal 0 0 -0.7 1
GSM1061132 1 3 6 perfect health 2 69 ductal 42 NA 0 2 1.4 1
GSM106113 0 1 6 perfect health 2 53 ductal 18 NA 0 0 -0.6 1
GSM1061130 1 1 6 perfect health 3 54 lobular 32 postmenopausal 1 0 -0.7 1
GSM1061129 1 1 6 major problems 2 63 ductal 35 NA 0 0 -1.1 1
GSM1061128 0 3 6 perfect health 3 38 ductal 17 premenopausal 0 0 2.4 0
GSM1061127 1 3 6 major problems 3 70 ductal 45 postmenopausal 0 1 1.6 1
GSM1061126 1 1 3 minor 2 53 lobular 8 postmenopausal 0 0 -1.2 1
GSM1061125 1 equivocal 3 minor 2 62 ductal 15 postmenopausal 0 0 -0.3 1
GSM1061124 1 equivocal 3 minor 2 58 ductal 18 postmenopausal 0 1 0.1 1
GSM1061123 1 1 3 minor 1 51 ductal 12 postmenopausal 0 0 -1 1
GSM1061122 1 equivocal 1 minor 2 43 ductal 13 premenopausal 0 0 -0.1 1
GSM106112 1 1 6 minor 1 56 lobular 20 postmenopausal 0 0 -1 1
GSM1061120 0 3 6 perfect health 3 45 ductal 13 premenopausal 0 1 1.2 1
GSM1061119 1 1 6 major problems 2 64 ductal 6 postmenopausal 0 0 -1.9 1
GSM1061118 0 3 6 major problems 3 87 ductal 45 postmenopausal 1 0 1.9 0
GSM1061117 1 1 6 minor 2 51 ductal 13 NA 0 1 -0.4 1
GSM1061116 1 1 6 minor 2 67 lobular 30 postmenopausal 0 0 -2.3 1
GSM1061115 1 1 6 average for age 1 84 ductal 13 postmenopausal 0 0 -0.8 1
GSM1061114 0 3 9 perfect health 2 56 ductal 9 postmenopausal 0 0 0.8 0
GSM1061113 0 3 9 perfect health 3 47 ductal 33 premenopausal 0 0 3.3 0
GSM1061112 1 1 9 perfect health 1 78 ductal 17 postmenopausal 0 0 -0.5 1
GSM106 0 3 6 NA 3 76 ductal 30 postmenopausal 1 2 1.6 0
GSM1061110 1 equivocal 6 major problems 2 53 ductal 15 NA 0 0 -0.1 1
GSM1061109 1 1 6 major problems 1 52 lobular 12 premenopausal 0 0 -2.3 1
GSM1061108 1 1 6 minor 2 47 ductal 16 NA 0 0 -1.5 1
GSM1061107 1 3 6 major problems 1 49 ductal 15 premenopausal 0 0 1 1
GSM1061106 1 3 6 perfect health 2 58 ductal 15 NA NA 0 0.7 1
GSM1061105 1 3 6 minor 3 77 ductal 22 postmenopausal 0 3 1.3 1
GSM1061104 0 equivocal 6 minor 2 60 ductal 9 postmenopausal 0 0 0.1 1
GSM1061103 0 3 6 average for age 2 75 ductal 25 postmenopausal 0 2 0.9 1
GSM1061102 1 3 6 minor 3 63 ductal 18 NA 1 1 0.8 1
GSM106110 1 1 6 perfect health 2 66 ductal 15 postmenopausal 0 0 -0.6 1
GSM1061100 0 3 6 perfect health 3 49 ductal 15 premenopausal 1 2 0.8 0
GSM1061099 1 3 9 perfect health 2 47 ductal 20 premenopausal 0 0 0.4 1
GSM1061098 1 3 9 perfect health 2 55 ductal 17 postmenopausal 0 0 2 1
GSM1061097 0 3 9 perfect health 2 44 ductal 26 premenopausal 0 0 0.7 1
GSM1061096 1 1 9 perfect health 2 64 ductal 13 postmenopausal 0 0 -1 1
GSM1061095 0 3 9 perfect health 2 64 ductal 32 postmenopausal 0 1 0.4 1
GSM1061094 1 1 9 perfect health 1 49 ductal 21 premenopausal 0 0 -0.6 1
GSM1061093 1 1 9 perfect health 2 44 ductal 15 premenopausal 0 0 -0.6 1
GSM1061092 1 3 9 perfect health 2 44 ductal 25 premenopausal 0 0 1.1 1
GSM106109 1 1 9 perfect health 2 42 lobular 17 premenopausal 0 0 -1.2 1
GSM1061090 0 3 9 perfect health 3 31 ductal 23 premenopausal 0 0 2.8 0
GSM1061089 1 equivocal 9 perfect health 2 53 ductal 19 premenopausal 0 0 -0.1 1
GSM1061088 0 1 9 average for age 3 82 lobular 27 postmenopausal 0 0 -0.3 0
GSM1061087 1 1 9 perfect health 1 64 ductal 12 postmenopausal 0 0 -0.8 1
GSM1061086 1 1 9 perfect health 2 61 ductal 15 postmenopausal 0 0 -0.4 1
GSM1061085 0 3 9 perfect health 3 73 lobular 22 postmenopausal 0 0 0.4 1
GSM1061084 0 3 9 average for age 3 82 ductal 22 postmenopausal 1 0 0.4 0
GSM1061083 1 1 9 perfect health 2 65 ductal 11 postmenopausal 0 1 -2.2 1
GSM1061082 0 3 9 perfect health 3 35 ductal 22 premenopausal 0 1 2.9 1
GSM106108 1 equivocal 2 perfect health 2 61 ductal 25 postmenopausal 0 1 -0.1 1
GSM1061080 1 1 2 minor 1 48 ductal 10 premenopausal 0 0 -2.5 1
GSM1061079 1 equivocal 2 minor 2 58 ductal 30 postmenopausal 0 1 0.2 1
GSM1061078 1 equivocal 2 minor 2 47 ductal 17 premenopausal 0 0 -0.1 1
GSM1061077 1 equivocal 1 minor 3 71 ductal 42 postmenopausal 0 0 0.1 1
GSM1061076 0 equivocal 1 average for age 2 71 ductal 12 postmenopausal 0 0 -0.1 0
GSM1061075 1 3 1 average for age 3 78 ductal 42 postmenopausal 1 0 0.6 1
GSM1061074 1 equivocal 1 minor 2 49 ductal 15 premenopausal 0 0 -0.2 1
GSM1061073 1 3 1 average for age 3 55 ductal 12 postmenopausal 0 0 1.3 1
GSM1061072 1 3 1 average for age 3 73 ductal 40 postmenopausal 0 3 1.5 1
GSM106107 1 1 1 perfect health 1 42 ductal 41 premenopausal 0 0 -0.8 1
GSM1061070 1 equivocal 1 major problems 1 81 ductal 14 postmenopausal 0 0 -0.2 1
GSM1061069 1 equivocal 6 minor 3 42 ductal 17 premenopausal 0 0 0.2 1
GSM1061068 1 equivocal 6 average for age 1 78 lobular 19 postmenopausal 0 0 -0.3 1
GSM1061067 1 3 6 perfect health 3 53 ductal 21 premenopausal 0 1 0.4 1
GSM1061066 0 1 9 perfect health 2 50 ductal 15 postmenopausal 1 0 -0.3 1
GSM1061065 0 3 9 perfect health 2 39 ductal 13 premenopausal 0 0 2.4 0
GSM1061064 1 equivocal 9 perfect health 2 53 lobular 28 postmenopausal 0 3 -0.2 1
GSM1061063 1 3 9 perfect health 3 41 ductal 28 premenopausal 0 1 1.5 1
GSM1061062 0 3 9 perfect health 3 46 ductal 32 premenopausal 0 0 3.1 0
GSM106106 0 1 3 minor 1 66 ductal 9 postmenopausal 0 0 -2 1
GSM1061060 0 3 3 major problems 3 69 ductal 21 postmenopausal 0 0 3.1 0
GSM1061059 1 3 3 major problems 2 60 ductal 24 postmenopausal 0 0 0.6 1
GSM1061058 1 3 3 minor 3 54 lobular 35 postmenopausal 0 0 0.9 1
GSM1061057 1 3 3 NA 3 71 ductal 19 postmenopausal 0 0 1.5 1
GSM1061056 1 equivocal 3 average for age 1 76 ductal 24 postmenopausal 0 0 -0.2 1
GSM1061055 1 equivocal 3 perfect health 1 78 ductal 18 postmenopausal 0 0 -0.3 1
GSM1061054 1 1 8 perfect health 3 73 ductal 44 postmenopausal 0 3 -0.6 1
GSM1061053 0 3 2 minor 3 48 ductal 11 premenopausal 0 0 1.2 0
GSM1061052 1 equivocal 2 minor 2 56 ductal 16 postmenopausal 1 2 0.3 1
GSM106105 1 1 2 minor 2 77 ductal 11 postmenopausal 0 1 -1 1
GSM1061050 1 1 2 minor 2 51 ductal 28 premenopausal 0 1 -1.5 1
GSM1061049 1 1 2 minor 1 67 ductal 18 postmenopausal 0 0 -2.3 1
GSM1061048 1 equivocal 2 perfect health 2 48 ductal 10 premenopausal 0 0 0 1
GSM1061047 1 1 6 perfect health 3 67 ductal 18 postmenopausal 0 1 -0.4 1
GSM1061046 0 3 6 perfect health 2 66 ductal 50 postmenopausal 0 0 0.7 1
GSM1061045 1 1 6 minor 1 72 ductal 11 postmenopausal 0 3 -1.8 1
GSM1061044 1 1 6 perfect health 2 53 ductal 12 NA 0 0 -1.3 1
GSM1061043 0 3 6 minor 3 54 ductal 45 postmenopausal 1 0 1.5 0
GSM1061042 0 3 6 perfect health 2 61 ductal 10 postmenopausal 0 0 0.6 1
GSM106104 1 equivocal 1 major problems 2 81 lobular 15 postmenopausal 0 0 0.1 1
GSM1061040 1 equivocal 1 minor 2 47 ductal 13 premenopausal 0 0 0 1
GSM1061039 0 3 1 NA 3 90 ductal 18 postmenopausal NA 0 0.4 0
GSM1061038 1 1 1 minor 2 61 lobular 11 postmenopausal 0 0 -0.8 1
GSM1061037 1 1 1 average for age 1 76 lobular 16 postmenopausal 0 0 -2.2 1
GSM1061036 0 3 1 perfect health 3 43 ductal 19 NA 0 0 2.5 0
GSM1061035 1 1 1 average for age 2 65 ductal 30 postmenopausal 0 0 -0.6 1
GSM1061034 0 3 4 average for age 2 59 ductal 10 postmenopausal 1 0 0.5 0
GSM1061033 1 3 4 major problems 2 60 ductal 22 postmenopausal 0 0 2.2 1
GSM1061032 1 3 6 perfect health 2 68 ductal 17 postmenopausal 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use